Erlotinib 183321-74-6
-
Post Date:
May 07,2019
-
Expiry Date:
Nov 03,2019
-
Detailed Description:
Cas No. :183321-74-6
Erlotinib hydrochloride is a drug used to treat non-small cell lung cancer (NSCLC), pancreatic cancer and several other types of cancer. It is a receptor tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR).
-
CAS Registry Number:
183321-74-6
-
Synonyms:
;4-[(3-ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline;n-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine;4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-;ERLOTININ;Erlotinib & its intermediates (Developing);Erlotinib Base;
-
Molecular Formula:
C22H23N3O4
-
Molecular Weight:
393.44
-
Molecular Structure:
Inquiry